- Home
- SBCF vs AMRX Comparison
SBCF vs AMRX Comparison
Compare SBCF & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- AMRX
- Stock Information
- Founded
- SBCF 1926
- AMRX 2002
- Country
- SBCF United States
- AMRX United States
- Employees
- SBCF N/A
- AMRX N/A
- Industry
- SBCF Major Banks
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SBCF Finance
- AMRX Health Care
- Exchange
- SBCF Nasdaq
- AMRX Nasdaq
- Market Cap
- SBCF 2.8B
- AMRX 2.9B
- IPO Year
- SBCF N/A
- AMRX N/A
- Fundamental
- Price
- SBCF $30.59
- AMRX $9.61
- Analyst Decision
- SBCF Buy
- AMRX Strong Buy
- Analyst Count
- SBCF 4
- AMRX 4
- Target Price
- SBCF $29.50
- AMRX $12.00
- AVG Volume (30 Days)
- SBCF 566.9K
- AMRX 1.5M
- Earning Date
- SBCF 10-23-2025
- AMRX 11-07-2025
- Dividend Yield
- SBCF 2.37%
- AMRX N/A
- EPS Growth
- SBCF 19.16
- AMRX N/A
- EPS
- SBCF 1.63
- AMRX 0.01
- Revenue
- SBCF $531,697,000.00
- AMRX $2,852,914,000.00
- Revenue This Year
- SBCF $28.39
- AMRX $9.56
- Revenue Next Year
- SBCF $34.82
- AMRX $6.27
- P/E Ratio
- SBCF $18.63
- AMRX $883.95
- Revenue Growth
- SBCF 5.40
- AMRX 9.81
- 52 Week Low
- SBCF $21.36
- AMRX $6.69
- 52 Week High
- SBCF $32.09
- AMRX $10.34
- Technical
- Relative Strength Index (RSI)
- SBCF 54.68
- AMRX 55.75
- Support Level
- SBCF $29.86
- AMRX $9.32
- Resistance Level
- SBCF $31.12
- AMRX $10.34
- Average True Range (ATR)
- SBCF 0.66
- AMRX 0.25
- MACD
- SBCF -0.15
- AMRX -0.04
- Stochastic Oscillator
- SBCF 32.74
- AMRX 31.78
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.